New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
337.32+3.61 (+1.08%)
At close: 04:00PM EDT
337.32 0.00 (0.00%)
After hours: 05:22PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close333.71
Open334.90
Bid335.91 x 900
Ask346.63 x 800
Day's range332.54 - 338.00
52-week range261.59 - 394.51
Volume205,414
Avg. volume254,812
Market cap9.348B
Beta (5Y monthly)0.93
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

    HERCULES, Calif., August 22, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company’s Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during Wells Fargo’s 2024 Healthcare Conference on Wednesday, September 4, at 2:15 PM Eastern Time (11:15 AM Pacific Time).

  • Business Wire

    Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

    HERCULES, Calif., August 20, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring.

  • Business Wire

    Bio-Rad Reports Second-Quarter 2024 Financial Results

    HERCULES, Calif., August 01, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2024.